带有PAK1/2/3融合的多瘤:一系列12例病例
Thibault Kervarrec1,2,3, Danna Westphal4,5, Daniel Pissaloux6,7
1Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France.
Histopathology
|May 24, 2024
概括
这项研究确定了PAK1/2/3基因融合作为一个关键驱动器,在一个子集的毛孔癌. 这些发现表明这种罕见的汗腺癌是一种新的治疗点.
科学领域:
- 在瘤学瘤学.
- 皮肤病理学 皮肤病理学
- 分子生物学分子生物学
背景情况:
- 毛囊癌是一种恶性汗腺瘤.
- 已知YAP1融合是毛孔癌的驱动因素.
- 在良性毛孔瘤中发现了PAK2融合.
研究的目的:
- 调查PAK1/2/3融合在毛孔癌中的作用.
- 在缺少YAP1重组的毛孔癌病例中识别瘤驱动因素.
主要方法:
- 对12例毛孔癌病例的分析.
- 整体RNA测序以识别基因融合.
- 针对瘤标记物的免疫组织化学染色.
主要成果:
- 在毛孔癌的一个子集中确定了PAK1/2/3的融合.
- 常见的融合包括LAMTOR1::PAK1,ZDHHC5::PAK1,以及DLG1::PAK2.
- 激活HRAS突变存在于六个病例中.
- 七个病例显示出一种混合的良性和恶性成分.
结论:
- PAK1/2/3融合是多孔癌的一个子集中的致癌驱动因素.
- 这一发现使它们与YAP1重新排列的多瘤有所区别.
- 建议PAK1/2/3融合作为潜在的治疗目标.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


